- Smart inhalers are advanced drug delivery devices integrated with digital technology to monitor inhaler usage, improve medication adherence, and provide real-time data to patients and healthcare providers. They are primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD)
- The demand for smart inhalers is significantly driven by the increasing global burden of respiratory diseases and growing adoption of digital health solutions to enhance treatment outcomes
- North America is expected to dominate the smart inhalers for respiratory diseases market with a market share of 39.5%, due to high prevalence of asthma and COPD, advanced digital healthcare infrastructure, and strong presence of leading market players
- Asia-Pacific is expected to be the fastest growing region in the smart inhalers for respiratory diseases market with a market share of 24.5%, during the forecast period due to growing healthcare digitization, rising respiratory disease burden, and increasing awareness about connected health solutions
- Inhalers segment is expected to dominate the market with a market share of 83.5% due to its widespread use in managing chronic respiratory conditions like asthma and COPD
